MarketCap
Facebook
X
Telegram
Merrimack Pharmaceuticals ROCE | MACK
ROCE Jährlich Merrimack Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.87 | -8.98 | -17.42 | -17.95 | -129.15 | -88.92 | -98.17 | 2186.18 | -110.64 | -62.68 | -89.5 | -83.96 | -138.06 | 22.36 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2186.18 | -138.06 | 96.59 |
ROCE Vierteljährlich Merrimack Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.45 | -8.14 | -11.97 | -12.71 | -10.66 | -8.33 | -11.92 | -13.25 | -14.1 | -13.16 | -19.18 | -22.41 | -16.13 | -11.71 | -15.92 | -33.02 | -46.71 | -47.84 | -72.8 | -96.2 | -95.01 | -74.49 | -89.69 | -97.16 | -59.68 | -37.76 | -27.23 | 2.8 | 49.1 | 39.22 | 66.34 | 68.76 | 77.17 | 63.31 | 87.1 | 78.01 | 100.7 | 77.47 | 298.39 | 324.7 | 391.7 | 356.05 | 169.49 | -113.45 | -155.85 | -240.88 | -234.46 | -42.86 | 7.7 | - | 6.42 | - | 5.04 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 391.7 | -240.88 | 9.93 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AbbVie
ABBV
|
-461.01 | $ 263.04 | 0.49 % | $ 465 B |  USA |
 |
AbCellera Biologics
ABCL
|
-16.8 | $ 11.41 | 2.15 % | $ 3.41 B |  Canada |
 |
Фармсинтез
LIFE
|
-4.03 | - | - | - |  Russia |
 |
Aclaris Therapeutics
ACRS
|
-74.09 | $ 5.53 | 6.02 % | $ 678 M | USA |
 |
ADC Therapeutics SA
ADCT
|
65.38 | $ 1.09 | 3.74 % | $ 139 M |  Schweiz |
 |
Amryt Pharma plc
AMYT
|
-5.86 | - | - | $ 621 M |  Britain |
 |
Evelo Biosciences
EVLO
|
2172.8 | - | -14.46 % | $ 27.9 M | USA |
 |
Allakos
ALLK
|
-155.07 | - | - | $ 28.6 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
-88.5 | - | - | $ 231 M | USA |
 |
Clovis Oncology
CLVS
|
18.9 | - | -7.23 % | $ 13 M | USA |
 |
Chimerix
CMRX
|
-79.36 | - | - | $ 756 M | USA |
 |
Concert Pharmaceuticals
CNCE
|
-69.06 | - | - | $ 401 M | USA |
 |
ADMA Biologics
ADMA
|
40.11 | $ 8.61 | 0.16 % | $ 2.05 B | USA |
 |
Eiger BioPharmaceuticals
EIGR
|
496.51 | - | -9.21 % | $ 2.55 M | USA |
|
89bio
ETNB
|
-95.97 | - | - | $ 1.55 B | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
-187.83 | - | - | $ 384 M | Britain |
 |
Fusion Pharmaceuticals
FUSN
|
-44.6 | - | - | $ 1.41 B | Canada |
 |
Guardion Health Sciences
GHSI
|
-53.23 | - | -0.31 % | $ 3.64 M | USA |
 |
Genocea Biosciences
GNCA
|
-192.4 | - | -15.0 % | $ 3.04 M | USA |
 |
Gritstone Oncology
GRTS
|
-269.28 | - | 0.42 % | $ 213 M | USA |
 |
G1 Therapeutics
GTHX
|
-111.7 | - | - | $ 370 M | USA |
 |
Harpoon Therapeutics
HARP
|
-1265.51 | - | - | $ 763 M | USA |
 |
Humanigen
HGEN
|
146.06 | - | -81.12 % | $ 4.28 M | USA |
 |
HOOKIPA Pharma
HOOK
|
-88.88 | - | -6.92 % | $ 79.4 M | USA |
 |
Intercept Pharmaceuticals
ICPT
|
-20.32 | - | - | $ 643 M | USA |
 |
IGM Biosciences
IGMS
|
-432.99 | - | - | $ 76.9 M | USA |
 |
IMV
IMV
|
-79.29 | - | - | $ 13.1 M | Canada |
 |
Intra-Cellular Therapies
ITCI
|
-10.16 | - | - | $ 13.6 B | USA |
 |
Kinnate Biopharma
KNTE
|
-76.05 | - | - | $ 123 M | USA |
 |
Chinook Therapeutics
KDNY
|
-41.88 | - | - | $ 2.6 B | USA |
 |
Kaleido Biosciences
KLDO
|
-826.5 | - | -3.69 % | $ 12.4 M | USA |
 |
Kronos Bio
KRON
|
-106.06 | - | 1.49 % | $ 50.8 M | USA |
 |
Karuna Therapeutics
KRTX
|
-39.45 | - | - | $ 12.2 B | USA |
 |
Landos Biopharma
LABP
|
-71.49 | - | 0.58 % | $ 144 M | USA |
 |
La Jolla Pharmaceutical Company
LJPC
|
-32.71 | - | - | $ 154 M | USA |
 |
LogicBio Therapeutics
LOGC
|
-126.88 | - | - | $ 229 M | USA |
 |
Lumos Pharma
LUMO
|
-134.09 | - | - | $ 35.3 M | USA |
 |
Stealth BioTherapeutics Corp
MITO
|
102.23 | - | - | $ 23.9 M | USA |
 |
Mirati Therapeutics
MRTX
|
-76.22 | - | - | $ 3.3 B | USA |
 |
NexImmune
NEXI
|
-939.5 | - | 70.13 % | $ 4.12 M | USA |
 |
9 Meters Biopharma
NMTR
|
-1750.31 | - | -42.97 % | $ 1.05 M | USA |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
-67.64 | - | -37.48 % | $ 476 K | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
63.22 | - | -19.68 % | $ 18.4 M | Canada |
 |
ObsEva SA
OBSV
|
-182.2 | - | -15.52 % | $ 10.5 M | Schweiz |
 |
Oncorus
ONCR
|
-126.46 | - | -8.54 % | $ 3.19 M | USA |
 |
OncoSec Medical Incorporated
ONCS
|
-604.93 | - | 31.87 % | $ 1.61 M | USA |
 |
Oncternal Therapeutics
ONCT
|
-138.81 | - | -24.12 % | $ 1.56 M | USA |
 |
Opiant Pharmaceuticals
OPNT
|
11.01 | - | - | $ 109 M | USA |
 |
Orchard Therapeutics plc
ORTX
|
-129.33 | - | 1.02 % | $ 90.8 M | Britain |